Inspiremd appoints acclaimed interventional cardiologist kenneth rosenfield, md as chair of its newly formed scientific advisory board

Tel aviv, israel, april 29, 2021 (globe newswire) -- inspiremd, inc. (nyse american: nspr), developer of the cguard™ embolic prevention system (eps) for the prevention of the stroke caused by carotid artery disease, today announces the formation of its scientific advisory board with its newly appointed chair, acclaimed interventional cardiologist, kenneth rosenfield, m.d.
NSPR Ratings Summary
NSPR Quant Ranking